01 1Shenzhen Hepalink Pharmaceutical
01 1HEPARIN SODIUM USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-31
Pay. Date : 2013-01-08
DMF Number : 17845
Submission : 2004-11-17
Status : Active
Type : II
20
Shenzhen Hepalink Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HEPARIN SODIUM USP, with a corresponding US DMF Number 17845.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2013, and payment made on January 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
